A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly Oral Dosage Forms
- 1.6k Downloads
Despite the fact that a significant percentage of the population is unable to swallow tablets and capsules, these dosage forms continue to be the default standard. These oral formulations fail many patients, especially children, because of large tablet or capsule size, poor palatability, and lack of correct dosage strength. The clinical result is often lack of adherence and therapeutic failure. The American Association of Pharmaceutical Scientists formed a Pediatric Formulations Task Force, consisting of members with various areas of expertise including pediatrics, formulation development, clinical pharmacology, and regulatory science, in order to identify pediatric, manufacturing, and regulatory issues and areas of needed research and regulatory guidance. Dosage form and palatability standards for all pediatric ages, relative bioavailability requirements, and small batch manufacturing capabilities and creation of a viable economic model were identified as particular needs. This assessment is considered an important first step for a task force seeking creative approaches to providing more appropriate oral formulations for children.
KEY WORDSchildren drugs formulations manufacturing palatability pediatrics regulatory
The authors would like to thank Drs. Philip Mayer and David Mitchell and AAPS for facilitating this effort and to Sharon Pichon of AAPS for facilitating the calls and meetings with the co-authors
- 1.Thompson KC. Extemporaneous formulations: Comparison with labeled pediatric formulations. American Pharmaceutical Review 2010 (March); 13(2).Google Scholar
- 5.EMEA Reflection Paper. Reflection paper formulations of choice for the paediatric population, 28 Jul 2006 EMEA/CHMP/PEG?194810/2005. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003782.pdf. Accessed 19 Jul 2013.
- 6.EMA Guideline on Pharmaceutical Development of Medicines for Paediatric Use. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2011/06/WC500107908.pdf. Accessed 19 Jul 2013.
- 10.FDA Guidance to Industry. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a Biopharmaceutics Classification System, 2000. http://www.fda.gov/downloads/Drugs/…/Guidances/ucm070246.pdf. Accessed 19 July 2013.
- 11.Abdel-Rahman S, Amidon GL, Kaul A, et al. Summary of the National Institute of Child Health and Human Development-Best Pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop-Pediatric Biopharmaceutics Classification System Working Group. Clin Ther. 2012;34(11):S11–24.PubMedCrossRefGoogle Scholar
- 19.Amidon G. Best Pharmaceuticals for Children Act Pediatric Formulations Initiative Workshop, Potomac, 2011, http://bpca.nichd.nih.gov/collaborativeefforts/upload/PFI_Workshop_11-1-2-11.pdf. Accessed 19 Jul 2013.
- 22.Inactive Ingredients Database URL: http://www.fda.gov/Drugs/InformationOnDrugs/ucm113978.htm. Accessed 19 Jul 2013.
- 23.European Union Pediatric Formulations Initiative. http://www.eupfi.org/. Accessed 19 Jul 2013.
- 35.Aziz MAHH, Jameela KA. How accurate are household spoons in drug administration? Med Princ Pract. 1990;2:106–9.Google Scholar
- 42.Booth, B. Pediatric formulations: what we want to know. Presentation to the FDA Pediatric Advisory Committee, 15 December 2009. www.fda.gov/downloads/AdvisoryCommittees/…/UCM197942.pdf. Accessed 19 Jul 2013.
- 44.Health Canada Guidance Document. Comparative bioavailability standards: formulations used for systemic effects. May 22, 2012. http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide- ld/bio/gd_standards_ld_normes-eng.php. Accessed 19 Jul 2013.
- 47.Johnson TN, Rostami-Hodjegan A. Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice. Paediatr Anaesth. 2011;21:291–301.PubMedCrossRefGoogle Scholar
- 51.Strachan I, Greener M. Medication-related swallowing difficulties may be more common than we realise. Pharm Pract. 2005;15:411–4.Google Scholar